Press release
Investigation announced for Long-Term Investors in shares of Annovis Bio, Inc. (NYSE: ANVS) over possible Wrongdoing
An investigation on behalf of current long term investors in Annovis Bio, Inc. (NYSE: ANVS) shares.
Investors who are current long term investors in Annovis Bio, Inc. (NYSE: ANVS) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NYSE: ANVS stocks follows a lawsuit filed against Annovis Bio, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NYSE: ANVS stocks, concerns whether certain Annovis Bio directors are liable in connection with the allegations made in that lawsuit.
According to that complaint filed in the U.S. District Court for the Eastern District of Pennsylvania the plaintiff alleges that the Defendants failed to disclose to investors: (1) that Annovis’s ANVS401 did not show statistically significant results across two patient populations as to factors such as orientation, judgement, and problem solving; and (2) as a result, Defendants’ statements about its business, operations, and prospects were materially false and misleading and/or lacked reasonable basis at all relevant times.
Those who purchased shares of Annovis Bio, Inc. (NYSE: ANVS) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Long-Term Investors in shares of Annovis Bio, Inc. (NYSE: ANVS) over possible Wrongdoing here
News-ID: 2442921 • Views: …
More Releases from Shareholders Foundation
Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to …
An investor, who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND), filed a lawsuit over alleged violations of Federal Securities Laws by Sonder Holdings Inc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: SOND investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover …
An investor, who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), filed a lawsuit i over alleged violations of Federal Securities Laws by Ocugen, Inc..
Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Malvern, PA based Ocugen, Inc., a…
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDA …
An investor, who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp.
Investors who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) have certain options and for certain investors are short and strict deadlines running. Deadline: May 24, 2024. NASDAQ: EVLV…
Investigation announced for Investors who purchased shares of Comtech Telecommun …
Comtech Telecommunications Corp is under investigation over potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Comtech Telecommunications Corp. regarding its business, its prospects and its operations were materially false…
More Releases for Annovis
Down Syndrome Market Global Scenario, Market Size, Outlook, Trend, and Forecast, …
The global down syndrome market is expected to reach US$ 3,575.8 Million by 2028. The market is expected to experience the growth rate of 15.3% from 2021 to 2028. Down Syndrome also known as Trisomy 21, is a genetic condition that occurs when cell division takes place incorrectly. Such incorrect cell divisions give rise to an extra chromosome number 21 which further leads to chromosomal deformities like Down Syndrome. Down…
Deadline on October 18th coming up in Lawsuit for Investors in shares of Annovis …
A deadline is coming up on October 18, 2021 in the lawsuit filed for certain investors of Annovis Bio, Inc. (NYSE: ANVS) over alleged securities laws violations by Annovis Bio, Inc.
Investors who purchased shares of Annovis Bio, Inc. (NYSE: ANVS) have certain options and there are strict and short deadlines running. Deadline: October 18, 2021. NYSE: ANVS stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
Lawsuit filed for Investors in shares of Annovis Bio, Inc. (NYSE: ANVS)
An investor, who purchased shares of Annovis Bio, Inc. (NYSE: ANVS), filed a lawsuit over alleged violations of Federal Securities Laws by Annovis Bio, Inc.
Investors who purchased shares of Annovis Bio, Inc. (NYSE: ANVS) have certain options and for certain investors are short and strict deadlines running. Deadline: October 18, 2021. NYSE: ANVS investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Berwyn, PA based Annovis…
Investigation announced for Investors in shares of Annovis Bio, Inc. (NYSE: ANVS …
Annovis Bio, Inc is under investigation over potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of Annovis Bio, Inc. (NYSE: ANVS), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Annovis Bio, Inc. regarding its business, its prospects and its operations were materially false…
Global Down syndrome market Surprising Growth due to Covid 19 include Major Play …
Key players in the market, major collaborations, merger and acquisitions along with trending innovation and business policies are reviewed in this persuasive Global Down Syndrome Market report. Besides, this market research report makes clients aware about the various strategies that are used by key players of the market. Competitor analysis is a vital aspect of this market research report which focuses on strong and weak points of the competitors and…
Down Syndrome Market Analysis of 2026 focusing on Top Players like OPKO Health, …
Global Down syndrome market is rising gradually with a substantial CAGR in the forecast period of 2019-2026. The high prevalence of Down syndrome, increasing governmental funding for development of novel therapies and rising awareness about the disease are the major drivers for the market growth.
Get Sample Report + All Related Graphs & Charts @
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-down-syndrome-market
Competitive Analysis:
Global Down syndrome market is highly fragmented and the major players have used various strategies such…
